Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice
Frontiers in Nutrition · 20.02.2023 · 10
DOI: 10.3389/fnut.2023.1094483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 20.02.2023. Verfasst von Zhihuan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Cente…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hyperuricemia (HUA) is a common metabolic disease, and its prevalence has been increasing worldwide. Pharmaceutical drugs have been used for controlling HUA but they all have certain side effects, which thus calls for discovering alternative options including using treatment of probiotics to prevent the development of HUA.
Methods
We established HUA mice model induced by potassium oxonate and adenine and performed in vivo experiments to verify the ability to lower serum uric acid of Lactiplantibacillus pentosus P2020 (LPP), a probiotics stain extracted from Chinese pickle. We also tried to discussed the underlying mechanisms.
Results
Oral administration with LPP significantly decreased serum uric acid and reduced renal inflammatory response by downregulating multiple inflammation pathways including NK-kB, MAPK, and TNFα. We also found that LPP administration significantly promoted uric acid excretion by regulating expression of transporters in the kidney and ileum. In addition, LPP intake improved intestinal barrier function and modulated the composition of gut microbiota.
Discussion
These results suggest that probiotics LPP may have a promising potential to protect against development of HUA and HUA-related renal damage, and its working mechanisms involve regulation of inflammation pathways and expression of transporters in the kidney and ileum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of U…
- Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Maiyata Institute for Beneficial Bacteria, Shaoxing, Zhejiang, China.
Zitieren
APA
Wang, Z., Song, L., Li, X., Xiao, Y., Huang, Y., Zhang, Y., Li, J., Li, M., & Ren, Z. (2023). Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1094483
Vancouver
Wang Z, Song L, Li X, Xiao Y, Huang Y, Zhang Y, et al. Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1094483
BibTeX
@article{Wang2023,
author = {Wang, Zhihuan and Song, Liqiong and Li, Xianping and Xiao, Yuchun and Huang, Yuanming and Zhang, Yue and Li, Jintong and Li, Mingding and Ren, Zhihong},
title = {Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice},
journal = {Frontiers in Nutrition},
year = {2023},
volume = {10},
doi = {10.3389/fnut.2023.1094483}
}
EUVIMED